Testing COVID-19

COVID-19 Testing Training Plan

Training Plan – COVID-19 Testing

Training Name: COVID-19 Testing

 

TrainingSimulationWorkshopPresentation

Training Objectives

1.     Attendees will verbalize the reasons COVID-19 testing is done in the facility

2.     Attendees will describe the types of COVID-19 testing

3.     Attendees will identify PPE necessary for testing

4.     Attendees will verbalize immediate follow-up for positive COVID-19 test results

 

Connection to Overall Project   Goals

·       This training is part of the overall project to educate and support nursing facility operators and staff regarding COVID-19 testing in accordance with regulatory compliance and best practices

Participants:

Who should attend?

For the purposes of this education, we will refer to the regulations and CDC guidance for COVID-19 testing for employees and residents

Education is offered in slide presentation form with speaker’s notes for use by each facility.

Participants:

Nursing Staff-RN, LPN, Nursing Assistant

Interdisciplinary Team

 

What training should they attend before this one?

  • No pre-requisite

 

What training should they attend after this?

 

  • Annually, new licensed nurse hire and as needed

Facilitators:

(How many trainers should participate and whom?)

One presenter will be needed to facilitate the presentation, discussion and post-test

 

 

 

 

 

 

 

 

 

 

Logistics Requirements

What is needed?

·       Communication slide presentation

·       Attendance Sheet

·       Room for training

·       Projector

·       Screen or other blank light-colored surface

 

·      Room for training

·      Projector

·      Screen or other blank light-colored surface

 

 

 

 

 

 

 

 

TRAINING RESOURCES

References and Resources

 

Centers for Disease Control and Prevention. Considerations for Interpreting Antigen Test Results in Nursing Homes. August 21, 2020: https://www.cdc.gov/coronavirus/2019-ncov/downloads/hcp/nursing-home-testing-algorithm-508.pdf

 

Centers for Disease Control and Prevention. Considerations for Use of SARS-CoV-2 Antigen Testing in Nursing Homes. Updated Dec. 28, 2020: https://www.cdc.gov/coronavirus/2019-ncov/hcp/nursing-homes-antigen-testing.html

 

Centers for Disease Control and Prevention. Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19. Updated Dec. 21, 2020: https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html

 

Centers for Disease Control and Prevention. Interim Guidance for Antigen Testing for SARS-CoV-2. Updated Dec. 16, 2020: https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antigen-tests-guidelines.html

 

Centers for Disease Control and Prevention. Performing Facility-wide SARS-CoV-2 Testing in Nursing Homes. May 19, 2020: https://www.cdc.gov/coronavirus/2019-ncov/hcp/nursing-homes-facility-wide-testing.html

 

Centers for Disease Control and Prevention. Testing Guidelines for Nursing Homes. Interim SARS-CoV-2 Testing Guidelines for Nursing Home Residents and Healthcare Personnel. Updated Oct. 16, 2020: https://www.cdc.gov/coronavirus/2019-ncov/hcp/nursing-homes-testing.html

 

Centers for Disease Control and Prevention. COVID-19 Testing Overview. Updated Dec. 7, 2020: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/testing.html

 

Centers for Disease Control and Prevention. Guidance for SARS-CoV-2 Point-of-Care Testing. Updated Dec. 26, 2020: https://www.cdc.gov/coronavirus/2019-ncov/lab/point-of-care-testing.html

 

Centers for Medicare & Medicaid Services: QSO-20-38-NH, Interim Final Rule (IFC), CMS-3401-IFC, Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency related to Long-Term Care (LTC) Facility Testing Requirements and Revised COVID19 Focused Survey Tool. August 26, 2020: https://www.cms.gov/files/document/qso-20-38-nh.pdf

 

Centers for Medicare & Medicaid Services: QSO-20-37-CLIA, NH, Interim Final Rule (IFC), CMS-3401-IFC, Updating Requirements for Reporting of SARS-CoV-2 Test Results by Clinical Laboratory Improvement Amendments of 1988 (CLIA) Laboratories, and Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency. August 26, 2020: https://www.cms.gov/files/document/qso-20-37-clianh.pdf

 

United States Food & Drug Administration. Coronavirus Testing Basics. https://www.fda.gov/consumers/consumer-updates/coronavirus-testing-basics

 

United States Food & Drug Administration. FAQs on Testing for SARS-CoV-2: https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/faqs-testing-sars-cov-2#general-screening-asymptomatic